136 related articles for article (PubMed ID: 37490747)
1. Liquid Chromatography-Mass Spectrometry Screening of Cyclophosphamide DNA Damage In Vitro and in Patients Undergoing Chemotherapy Treatment.
Guidolin V; Jacobs FC; MacMillan ML; Villalta PW; Balbo S
Chem Res Toxicol; 2023 Aug; 36(8):1278-1289. PubMed ID: 37490747
[TBL] [Abstract][Full Text] [Related]
2. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
Spielmann H; Jacob-Müller U
Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
[TBL] [Abstract][Full Text] [Related]
3. Quantitative high-performance liquid chromatography-electrospray ionization tandem mass spectrometry analysis of bis-N7-guanine DNA-DNA cross-links in white blood cells of cancer patients receiving cyclophosphamide therapy.
Malayappan B; Johnson L; Nie B; Panchal D; Matter B; Jacobson P; Tretyakova N
Anal Chem; 2010 May; 82(9):3650-8. PubMed ID: 20361772
[TBL] [Abstract][Full Text] [Related]
4. Covalent DNA-Protein Cross-Linking by Phosphoramide Mustard and Nornitrogen Mustard in Human Cells.
Groehler A; Villalta PW; Campbell C; Tretyakova N
Chem Res Toxicol; 2016 Feb; 29(2):190-202. PubMed ID: 26692166
[TBL] [Abstract][Full Text] [Related]
5. Formation of cyclophosphamide specific DNA adducts in hematological diseases.
Johnson LA; Malayappan B; Tretyakova N; Campbell C; MacMillan ML; Wagner JE; Jacobson PA
Pediatr Blood Cancer; 2012 May; 58(5):708-14. PubMed ID: 21793181
[TBL] [Abstract][Full Text] [Related]
6. Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy.
Guidolin V; Li Y; Jacobs FC; MacMillan ML; Villalta PW; Hecht SS; Balbo S
Mol Ther Oncolytics; 2023 Mar; 28():197-210. PubMed ID: 36820303
[TBL] [Abstract][Full Text] [Related]
7. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide.
Plowchalk DR; Mattison DR
Toxicol Appl Pharmacol; 1991 Mar; 107(3):472-81. PubMed ID: 2000634
[TBL] [Abstract][Full Text] [Related]
8. Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast: comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustard.
Fleer R; Brendel M
Chem Biol Interact; 1982 Mar; 39(1):1-15. PubMed ID: 7037214
[TBL] [Abstract][Full Text] [Related]
9. Acrolein: unwanted side product or contribution to antiangiogenic properties of metronomic cyclophosphamide therapy?
Günther M; Wagner E; Ogris M
J Cell Mol Med; 2008 Dec; 12(6B):2704-16. PubMed ID: 18266977
[TBL] [Abstract][Full Text] [Related]
10. Reactions of nitrogen mustards with DNA.
Hemminki K; Kallama S
IARC Sci Publ; 1986; (78):55-70. PubMed ID: 3583398
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of DNA Adducts and Abasic Site Formation in Tissues of Mice Treated with a Nitrogen Mustard.
Chen H; Cui Z; Hejazi L; Yao L; Walmsley SJ; Rizzo CJ; Turesky RJ
Chem Res Toxicol; 2020 Apr; 33(4):988-998. PubMed ID: 32174110
[TBL] [Abstract][Full Text] [Related]
12. Screening for DNA Alkylation Mono and Cross-Linked Adducts with a Comprehensive LC-MS(3) Adductomic Approach.
Stornetta A; Villalta PW; Hecht SS; Sturla SJ; Balbo S
Anal Chem; 2015 Dec; 87(23):11706-13. PubMed ID: 26509677
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
Crook TR; Souhami RL; McLean AE
Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
[TBL] [Abstract][Full Text] [Related]
14. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
Struck RF; Alberts DS
Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
[TBL] [Abstract][Full Text] [Related]
15. Phosphoramide mustard exposure induces DNA adduct formation and the DNA damage repair response in rat ovarian granulosa cells.
Ganesan S; Keating AF
Toxicol Appl Pharmacol; 2015 Feb; 282(3):252-8. PubMed ID: 25497287
[TBL] [Abstract][Full Text] [Related]
16. Characterization of adducts formed in reactions of acrolein with thymidine and calf thymus DNA.
Pawłowicz AJ; Kronberg L
Chem Biodivers; 2008 Jan; 5(1):177-88. PubMed ID: 18205121
[TBL] [Abstract][Full Text] [Related]
17. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Identification of Adducts from the New Hypoxia-Activated Prodrug CP-506 Using DNA Adductomics.
Solivio MJ; Stornetta A; Gilissen J; Villalta PW; Deschoemaeker S; Heyerick A; Dubois L; Balbo S
Chem Res Toxicol; 2022 Feb; 35(2):275-282. PubMed ID: 35050609
[TBL] [Abstract][Full Text] [Related]
19. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue.
Liu X; Lovell MA; Lynn BC
Anal Chem; 2005 Sep; 77(18):5982-9. PubMed ID: 16159131
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells.
Schwartz PS; Waxman DJ
Mol Pharmacol; 2001 Dec; 60(6):1268-79. PubMed ID: 11723234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
